Nifty
Sensex
:
:
10829.35
36701.16
88.00 (0.82%)
228.23 (0.63%)

Pharmaceuticals & Drugs

Rating :
65/99  (View)

BSE: 512529 | NSE: SEQUENT

70.00
0.65 (0.94%)
23-Aug-2019 | 3:49PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  68.90
  •  70.75
  •  67.75
  •  69.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  109122
  •  76.39
  •  89.25
  •  42.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,713.28
  • 30.14
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,959.35
  • 0.29%
  • 2.44

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 56.50%
  • 11.39%
  • 13.83%
  • FII
  • DII
  • Others
  • 8.02%
  • 3.82%
  • 6.44%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.83
  • 17.43
  • 14.99

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.58
  • 43.56
  • 25.25

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.66
  • -28.74
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 3.37

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.09
  • 6.24
  • 2.68

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 56.41
  • 82.95
  • 26.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
278.02
235.15
18.23%
281.90
232.76
21.11%
270.53
224.92
20.28%
251.72
197.54
27.43%
Expenses
239.57
212.64
12.66%
242.90
202.51
19.94%
234.84
206.16
13.91%
223.99
178.65
25.38%
EBITDA
38.44
22.52
70.69%
39.00
30.25
28.93%
35.69
18.76
90.25%
27.73
18.89
46.80%
EBIDTM
13.83%
9.58%
13.83%
13.00%
13.19%
8.34%
11.02%
9.57%
Other Income
1.31
1.81
-27.62%
2.43
2.92
-16.78%
1.99
3.44
-42.15%
2.44
6.60
-63.03%
Interest
8.95
7.78
15.04%
8.90
9.68
-8.06%
8.35
9.87
-15.40%
7.77
7.42
4.72%
Depreciation
12.01
9.64
24.59%
10.92
9.48
15.19%
11.16
11.73
-4.86%
10.20
10.05
1.49%
PBT
18.80
6.91
172.07%
21.60
12.51
72.66%
18.17
0.60
2,928.33%
12.20
8.03
51.93%
Tax
3.50
2.43
44.03%
0.28
4.08
-93.14%
2.60
3.63
-28.37%
-3.30
3.83
-
PAT
15.30
4.48
241.52%
21.33
8.43
153.02%
15.57
-3.03
-
15.50
4.20
269.05%
PATM
5.50%
1.91%
7.57%
3.62%
5.76%
-1.35%
6.16%
2.13%
EPS
0.47
0.13
261.54%
0.70
16.39
-95.73%
0.53
-0.39
-
0.62
1.20
-48.33%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
1,082.17
1,039.31
1,268.48
683.57
624.98
465.36
455.46
326.86
345.81
311.89
284.45
Net Sales Growth
21.54%
-18.07%
85.57%
9.37%
34.30%
2.17%
39.34%
-5.48%
10.88%
9.65%
 
Cost Of Goods Sold
559.61
543.01
462.17
356.70
311.71
240.72
243.65
181.72
192.27
162.01
127.65
Gross Profit
522.56
496.30
806.32
326.87
313.27
224.65
211.81
145.14
153.53
149.87
156.80
GP Margin
48.29%
47.75%
63.57%
47.82%
50.12%
48.27%
46.50%
44.40%
44.40%
48.05%
55.12%
Total Expenditure
941.30
914.37
764.86
643.03
568.27
444.87
438.68
342.51
308.74
266.39
229.58
Power & Fuel Cost
-
23.06
14.66
12.77
26.51
23.32
22.06
23.53
20.21
16.75
14.40
% Of Sales
-
2.22%
1.16%
1.87%
4.24%
5.01%
4.84%
7.20%
5.84%
5.37%
5.06%
Employee Cost
-
145.95
113.83
106.22
88.62
62.39
48.12
41.47
29.40
29.82
27.57
% Of Sales
-
14.04%
8.97%
15.54%
14.18%
13.41%
10.57%
12.69%
8.50%
9.56%
9.69%
Manufacturing Exp.
-
77.73
59.07
57.63
72.14
54.31
52.30
41.42
27.88
33.72
29.76
% Of Sales
-
7.48%
4.66%
8.43%
11.54%
11.67%
11.48%
12.67%
8.06%
10.81%
10.46%
General & Admin Exp.
-
78.72
57.35
48.60
36.44
33.79
43.58
23.96
13.69
15.95
17.85
% Of Sales
-
7.57%
4.52%
7.11%
5.83%
7.26%
9.57%
7.33%
3.96%
5.11%
6.28%
Selling & Distn. Exp.
-
36.29
36.87
28.78
17.46
20.27
12.30
10.51
9.23
7.52
7.01
% Of Sales
-
3.49%
2.91%
4.21%
2.79%
4.36%
2.70%
3.22%
2.67%
2.41%
2.46%
Miscellaneous Exp.
-
9.61
20.92
32.34
15.40
10.07
16.66
19.91
16.05
0.63
7.01
% Of Sales
-
0.92%
1.65%
4.73%
2.46%
2.16%
3.66%
6.09%
4.64%
0.20%
1.88%
EBITDA
140.86
124.94
503.62
40.54
56.71
20.49
16.78
-15.65
37.07
45.50
54.87
EBITDA Margin
13.02%
12.02%
39.70%
5.93%
9.07%
4.40%
3.68%
-4.79%
10.72%
14.59%
19.29%
Other Income
8.17
8.67
16.58
11.08
14.30
9.96
3.84
4.96
10.48
6.69
30.02
Interest
33.97
32.80
33.07
28.34
38.56
44.37
39.04
33.45
29.99
23.80
21.66
Depreciation
44.29
41.92
41.34
40.07
46.22
32.94
32.60
28.61
22.98
20.69
14.24
PBT
70.77
58.88
445.79
-16.80
-13.77
-46.85
-51.00
-72.75
-5.41
7.69
48.98
Tax
3.08
2.01
13.46
-0.41
2.62
3.39
0.58
-8.06
-3.95
7.51
8.53
Tax Rate
4.35%
3.41%
3.03%
2.44%
-19.03%
-40.50%
-0.53%
11.08%
73.01%
215.80%
21.59%
PAT
67.70
48.66
421.57
-13.83
-18.47
-10.74
-110.49
-64.69
-1.40
-0.17
37.42
PAT before Minority Interest
56.84
56.88
430.83
-16.39
-16.39
-11.76
-110.49
-64.69
-1.46
-4.02
30.97
Minority Interest
-10.86
-8.22
-9.26
2.56
-2.08
1.02
0.00
0.00
0.06
3.85
6.45
PAT Margin
6.26%
4.68%
33.23%
-2.02%
-2.96%
-2.31%
-24.26%
-19.79%
-0.40%
-0.05%
13.16%
PAT Growth
380.82%
-88.46%
3148.23%
25.12%
-71.97%
90.28%
-70.80%
-4520.71%
-723.53%
-100.45%
 
Unadjusted EPS
2.32
2.00
17.40
-0.57
-0.92
-0.75
-42.76
-29.56
-0.64
-0.08
17.62

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
706.69
647.58
976.79
945.71
91.27
56.73
95.00
122.53
123.06
111.78
Share Capital
49.37
48.75
48.75
47.65
30.48
26.74
23.44
21.34
21.23
21.93
Total Reserves
638.43
581.25
912.49
874.01
26.85
-0.37
59.68
101.19
101.82
90.55
Non-Current Liabilities
218.53
227.13
246.20
299.72
277.55
159.23
144.35
104.79
123.22
182.42
Secured Loans
126.94
85.14
141.76
197.50
249.97
150.52
137.32
80.19
90.73
153.27
Unsecured Loans
20.90
18.40
23.38
13.82
0.35
0.56
0.72
0.88
8.46
21.85
Long Term Provisions
34.29
28.54
34.76
28.66
25.70
8.03
6.09
15.49
11.74
0.00
Current Liabilities
433.33
430.93
663.55
290.37
406.09
405.28
345.41
329.56
199.21
84.66
Trade Payables
209.35
160.49
203.04
143.94
90.94
114.59
150.91
123.94
82.61
57.71
Other Current Liabilities
96.32
106.52
259.26
83.23
107.43
56.80
35.63
75.38
37.71
5.30
Short Term Borrowings
118.84
152.41
194.70
56.04
204.31
226.60
151.76
123.34
69.09
0.00
Short Term Provisions
8.81
11.51
6.54
7.17
3.42
7.29
7.12
6.89
9.80
21.66
Total Liabilities
1,398.80
1,342.62
1,903.76
1,538.02
921.84
625.82
589.34
562.37
446.25
381.97
Net Block
498.14
475.97
684.33
586.48
474.43
237.59
227.26
229.76
210.76
184.95
Gross Block
638.06
581.74
789.60
643.70
596.25
369.07
330.69
305.11
264.26
226.06
Accumulated Depreciation
139.91
105.77
105.27
57.22
121.82
131.48
103.43
75.35
53.50
41.11
Non Current Assets
798.82
804.61
1,176.02
1,047.48
612.00
359.87
358.31
351.94
282.23
208.61
Capital Work in Progress
22.61
18.04
32.55
23.52
39.06
43.04
88.71
64.07
19.53
23.63
Non Current Investment
179.65
221.73
363.97
360.58
58.04
0.04
1.64
0.04
0.05
0.03
Long Term Loans & Adv.
35.10
32.42
37.51
30.35
36.01
76.06
39.28
55.77
50.87
0.00
Other Non Current Assets
63.31
56.44
57.66
46.54
4.47
3.15
1.42
2.30
1.02
0.00
Current Assets
599.99
538.01
727.74
490.54
309.84
265.94
231.04
210.42
164.02
173.36
Current Investments
0.47
17.34
64.12
66.98
0.58
0.08
0.18
0.28
0.33
0.51
Inventories
200.10
158.57
160.81
135.08
94.36
101.40
85.62
68.24
65.55
56.31
Sundry Debtors
278.25
258.35
254.62
192.39
115.44
83.54
65.81
70.41
55.45
55.38
Cash & Bank
72.04
42.45
47.40
25.30
38.46
36.21
33.00
35.88
9.17
14.07
Other Current Assets
49.12
5.25
146.31
24.11
61.01
44.71
46.44
35.62
33.52
47.08
Short Term Loans & Adv.
41.31
56.05
54.48
46.69
41.86
37.47
36.48
28.84
31.25
38.25
Net Current Assets
166.66
107.08
64.19
200.17
-96.25
-139.34
-114.37
-119.13
-35.19
88.70
Total Assets
1,398.81
1,342.62
1,903.76
1,538.02
921.84
625.81
589.35
562.36
446.25
381.97

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
116.02
45.24
-7.19
-0.05
-23.55
-44.78
-3.82
21.48
49.63
16.89
PBT
58.88
445.79
-16.80
-13.77
-8.37
-109.91
-72.75
-5.41
3.49
39.49
Adjustment
84.46
-313.85
123.31
83.81
35.92
133.52
65.98
46.98
36.77
27.17
Changes in Working Capital
-27.94
-77.87
-104.37
-71.46
-53.98
-67.45
2.48
-17.29
15.96
-46.23
Cash after chg. in Working capital
115.40
54.06
2.14
-1.42
-26.44
-43.84
-4.28
24.27
56.22
20.44
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.62
-8.83
-9.33
1.37
2.89
-0.95
0.46
-2.79
-6.59
-3.54
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-67.69
7.17
-116.18
-315.83
-154.69
-79.95
-54.89
-66.78
-71.77
-4.06
Net Fixed Assets
-32.63
221.87
-49.63
97.97
38.51
-26.62
-28.82
-41.67
-80.90
-111.64
Net Investments
-101.61
210.25
0.26
-713.97
-118.07
-10.37
-15.66
-25.20
31.50
-21.31
Others
66.55
-424.95
-66.81
300.17
-75.13
-42.96
-10.41
0.09
-22.37
128.89
Cash from Financing Activity
-20.08
-56.96
147.44
308.69
179.41
145.54
34.70
61.94
16.51
-5.95
Net Cash Inflow / Outflow
28.25
-4.55
24.07
-7.19
1.17
20.80
-24.02
16.63
-5.62
6.89
Opening Cash & Equivalents
39.54
44.10
20.03
21.85
22.96
3.45
27.37
9.17
14.07
4.10
Closing Cash & Equivalent
67.79
39.54
44.10
20.03
21.83
22.96
3.45
27.37
9.17
14.07

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
27.86
25.85
39.44
38.69
3.76
1.97
7.09
11.48
11.59
10.26
ROA
4.15%
26.54%
-0.95%
-1.33%
-1.52%
-18.19%
-11.23%
-0.29%
-0.97%
9.72%
ROE
8.63%
54.15%
-1.74%
-3.35%
-28.10%
-201.83%
-62.91%
-1.19%
-3.42%
40.48%
ROCE
9.28%
40.72%
0.87%
2.72%
6.93%
-16.09%
-9.86%
6.98%
9.11%
28.82%
Fixed Asset Turnover
1.70
1.85
0.96
1.03
1.01
1.36
1.08
1.26
1.31
1.66
Receivable days
94.23
73.71
118.40
87.75
74.80
57.30
72.70
64.08
63.08
59.42
Inventory Days
62.98
45.89
78.37
65.41
73.58
71.75
82.12
68.11
69.36
55.33
Payable days
75.43
89.49
104.11
77.28
87.31
115.68
149.32
123.09
94.20
96.41
Cash Conversion Cycle
81.78
30.11
92.66
75.87
61.07
13.36
5.51
9.10
38.25
18.34
Total Debt/Equity
0.46
0.48
0.43
0.34
8.26
15.86
3.74
2.19
1.54
1.56
Interest Cover
2.80
14.44
0.41
0.64
0.81
-1.82
-1.18
0.82
1.15
2.82

News Update


  • Sequent Scientific’s arm gets EIR for analytical laboratory at Bengaluru
    20th Aug 2019, 12:38 PM

    The company has received EIR from US Food and Drug Administration

    Read More
  • Sequent Scientific - Quarterly Results
    31st Jul 2019, 13:24 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.